M&A: Venture Medical Acquires Wound Care EHR Startup Medipyxis to Unify Clinical Documentation and Billing

What You Should Know

• Advanced wound care solutions enterprise Venture Medical, LLC announced the acquisition of Medipyxis, Inc., developer of a purpose-built electronic medical record (EMR) and practice operating system engineered specifically for wound care providers; financial terms were not disclosed.
• Medipyxis will operate as a wholly owned subsidiary of Venture Medical, maintaining its standalone platform roadmap under the continued executive leadership of founder Damon Ebanks, who will serve as President of Medipyxis.
• Medipyxis replaces fragmented point solutions by delivering an end-to-end clinical and administrative operating spine, combining AI-assisted referral intake, structured wound documentation aligned to Medicare Local Coverage Determinations (LCDs), real-time eligibility verification, automated scheduling and mobile clinician route planning, credentialing alerts, product inventory tracking, and claims billing.
• The acquisition pairs Venture Medical’s established advanced biologic formulary—including cellular and tissue-based products (CTPs / skin substitutes), wound bed preparation systems, and clinical supplies—with native software infrastructure to secure billing defensibility and supply chain reconciliation at the bedside.

Purpose-Built Operating System for Specialized Wound Care

Founded in 2024, Medipyxis was engineered to replace the fragmented, manual point solutions—spreadsheets, third-party route planners, generic EMRs, and fax queues—that create administrative drag in mobile, office-based, and facility-based wound care practices:

• End-to-End Workflow Architecture: Connects the complete clinical lifecycle from patient intake through billable claim drop within a single interface.
• Clinical Documentation Aligned to Coverage Mandates: Features structured wound assessment and tracking tools specifically mapped to Medicare coverage guidelines and local coverage determinations (LCDs), ensuring documentation defenses withstand heightened regulatory audits and WISeR prior authorization reviews.
• Front-End & Operational Automation: Integrates AI-assisted referral ingestion, real-time insurance eligibility checks, and proactive clinician credentialing tracking alerts.
• Field Logistics & Supply Chain Integration: Incorporates mobile route optimization and patient scheduling for traveling wound care clinicians, alongside tight inventory tracking for advanced biologics, dressings, and cellular and tissue-based products (CTPs / skin substitutes).

“The reduced payment changes did not reduce the number of patients who need wound care. The need continues to grow. What the changes have done is reduced the margin for inefficiency,” said John Schroeder, Chief Executive Officer of Venture Medical.

We intend to give Medipyxis the resources to bring its platform to more practices and patients.”